Preimplantation genetic screening outcomes are associated with culture conditions
Author(s) -
Claire E. Beyer,
Tiki Osianlis,
Kym Boekel,
Elissa Osborne,
Luk Rombauts,
James Catt,
V. Kralevski,
Bibi Shahnaz Aali,
Lyn Gras
Publication year - 2009
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/den502
Subject(s) - aneuploidy , blastomere , in vitro fertilisation , embryo , biopsy , medicine , genetic testing , selection (genetic algorithm) , biology , andrology , gynecology , obstetrics , genetics , embryogenesis , chromosome , artificial intelligence , computer science , gene
Although preimplantation genetic screening (PGS) is widely offered, there are contradictory reports on the clinical merit of this procedure. Any gain from embryo selection following aneuploidy screening must significantly outweigh the impact of the procedure. Variability of technical expertise in embryo biopsy, blastomere fixation, fluorescence in situ hybridization analysis, along with suboptimal laboratory quality control and inappropriate patient selection may impact PGS outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom